SNHG1 and osteoporosis: Compared with the pre-treatment levels of plasma SNHG1, plasma levels of SNHG1 were significantly increased in the 76 postmenopausal osteoporosis patients at 3 months (post-treatment) after the beginning of treatment (Figure 4, P<0.05).